I have been traveling and neglecting my duties at Secondhand Smoke. Whilst gone, readers alerted me to the pathetic excuse given by the New York Times
for not reporting the amniotic fluid
stem cell breakthrough. Its reporter, Nicolas Wade, claimed he didn't report it because the study was merely a "minor" matter. Yet, less important ESCR stories have been prominently reported in the Gray Lady. Moreover the story was front page news in the Washington Post
, San Francisco Chronicle
, and other MSM outlets. Hmmm. Could it be--bias?
Not to worry. I may have been asleep at the switch but Michael Fumento was on the case.
He also chides Newsweek
for reporting that human trials with placental stem cells will not happen for years, when apparently, at least one
is already under way. Way to go, Michael!